Company Active LTD

Company profile

BCS Clinical Consulting Limited

Software as a Medical Device - BCS Clinical Consulting

Quality, regulatory compliance, safety risk management and information governance consultancy for the software as a medical device and medical apps industry.

CRN
07767226
Founded
2011
Age
14

Overview

Legal name
BCS CLINICAL CONSULTING LIMITED
Region
Unknown
Registered address
43 MILL STREET
CLOWNE
CHESTERFIELD
DERBYSHIRE
ENGLAND
S43 4JN
Insolvency history
No

Latest accounts

Financial period: 1 Oct 2023 to 30 Sep 2024

FULLACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
1

Company events

Reference milestones and recent Companies House filing stream events.

6 events
22 Sep
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

30 Jun
2026

Accounts due

Accounts Due

Next accounts due date

08 Sep
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

12 Oct
2024

Confirmation Statement With No Updates

Confirmation-statement

CS01 | Transaction MzQzOTIzMjc0NWFkaXF6a2N4

Published 12 Oct 2024 08:40

30 Sep
2024

Accounts filed

Accounts

Last accounts made up date

08 Sep
2011

Incorporated

Inception

Company registered at Companies House

Public funding

2 awards
First funded
2021
Funded years
2021, 2023
Age at first award
9 years

Projects

2023 Collaborative R&D

Large Language Models based algorithms for personalised cancer detection

1 Nov 2023 to 31 Jul 2025

Awarded
£7,024
Total cost £10,034

More than a thousand patients are diagnosed with cancer daily in the UK - **1 in 2 people will get this diagnosis in their lifetime**. Many cancers being diagnosed at an advanced stage when treatments are less effective. The UK has poorer cancer survival rates compared to other high-income countries. The long-term plan aims to be diagnosing 75% of cancer ...

2021 Collaborative R&D

CanDetect: AI based early cancer detection using unstructured data

1 Jul 2021 to 30 Jun 2023

Awarded
£7,560
Total cost £10,800

UK cancer survival rates lag behind other developed countries(1), up to 10,000 excess deaths occur annually in comparison(2). Delayed diagnosis is thought to contribute to this(3). Currently nearly half of all cancers are diagnosed at a late stage(4). Approximately 20% of patients see their GP 3 or more times before their cancer diagnosis(7) with approxim...

Product types

Collaborative R&D